• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

0.9570 -0.0830 (-7.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CASI Pharmaceuticals, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR)
January 15, 2026
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia
January 12, 2026
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
December 23, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
December 11, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
December 08, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Changes in Board Governance
November 19, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
November 14, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
November 10, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference
November 04, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
November 03, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 13, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
September 26, 2025
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million. 
Via Benzinga
News headline image
CASI Pharmaceuticals Appoints James Huang to Board of Directors
September 26, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
September 08, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors
September 02, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 29, 2025
 
Via Benzinga
News headline image
CASI Pharmaceuticals Announces Second Quarter 2025 Business and Financial Results
August 29, 2025
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
August 28, 2025
Via ACCESS Newswire
News headline image
These stocks are moving in today's pre-market session ↗
August 18, 2025
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 18, 2025
 
Via Benzinga
News headline image
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗
August 18, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 15, 2025
 
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
August 15, 2025
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Top movers in Friday's session ↗
August 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
What's going on in today's session ↗
August 04, 2025
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
August 04, 2025
 
Via Benzinga
News headline image
Loop Industries (NASDAQ: LOOP) Ignites Paradigm Shift – Twist™ A Breakthrough in Circular Sustainability – More Stocks Inside
August 04, 2025
Via AB Newswire
Topics Economy
News headline image
Top stock movements in today's session. ↗
August 04, 2025
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
August 04, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap